Tumor necrosis factor-alpha enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells

Mol Pharmacol. 2008 May;73(5):1454-64. doi: 10.1124/mol.107.038091. Epub 2008 Jan 28.

Abstract

Up-regulation of vascular cell adhesion molecule-1 (VCAM-1) involves adhesions between both circulating and resident leukocytes and the human tracheal smooth muscle cells (HTSMCs) during airway inflammatory reaction. We have demonstrated previously that tumor necrosis factor (TNF)-alpha-induced VCAM-1 expression is regulated by mitogen-activated protein kinases, nuclear factor-kappaB, and p300 activation in HTSMCs. In addition to this pathway, phosphorylation of Akt and CaM kinase II has been implicated in histone acetyltransferase and histone deacetylase 4 (HDAC4) activation. Here, we investigated whether these different mechanisms participated in TNF-alpha-induced VCAM-1 expression and enhanced neutrophil adhesion. TNF-alpha significantly increased HTSMC-neutrophil adhesions, and this effect was associated with increased expression of VCAM-1 on the HTSMCs and was blocked by the selective inhibitors of Src [4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]-pyrimidine (PP1)], epidermal growth factor receptor [EGFR; 4-(3'-chloroanilino)-6,7-dimethoxy-quinazoline, (AG1478)], phosphatidylinositol 3-kinase (PI3K) [2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride(LY294002) and wortmannin],calcium[1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester; BAPTA-AM], phosphatidylinositol-phospholipase C (PLC) [1-[6-[[17beta-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122)], protein kinase C (PKC) [12-(2-cyanoethyl)-6,7,12, 13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole (Gö6976), rottlerin, and 3-1-[3-(amidinothio)propyl-1H-indol-3-yl]-3-(1-methyl-1H-indol-3-yl) maleimide (bisindolylmaleimide IX) (Ro 31-8220)], CaM (calmidazolium chloride), CaM kinase II [(8R(*),9S(*),11S(*))-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-14-n-propoxy-2,3,9, 10-tetrahydro-8,11-epoxy, 1H,8H, 11H-2,7b,11a-triazadibenzo[a,g]cycloocta[cde]trinden-1-one (KT5926) and 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-l-tyrosyl]-4-phenylpiperazine (KN62)], p300 (curcumin), and HDAC (trichostatin A) or transfection with short interfering RNAs for Src, Akt, PKCalpha, PKCmu, and HDAC4. At gene regulation level, reverse-transcriptase polymerase chain reaction and promoter assays revealed that expression of VCAM-1 was also attenuated by these signaling molecule inhibitors. Moreover, TNF-alpha induced Akt and CaM kinase II phosphorylation via cascades through Src/EGFR/PI3K and PLC/calcium/CaM, respectively. Finally, activation of Akt and CaM kinase II may eventually lead to the acetylation of histone residues and phosphorylation of histone deacetylase. These findings revealed that TNF-alpha induced VCAM-1 expression via multiple signaling pathways. Blockade of these pathways may be selectively targeted to reduce neutrophil adhesion via VCAM-1 suppression and attenuation of the inflammatory responses in airway diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Antibodies / pharmacology
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Calmodulin / metabolism
  • Cell Adhesion / drug effects
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Chromones / pharmacology
  • E1A-Associated p300 Protein / metabolism
  • Enzyme Activation / drug effects
  • Gene Expression Regulation / drug effects
  • Histone Acetyltransferases / metabolism
  • Histone Deacetylases / metabolism*
  • Humans
  • Isoenzymes / metabolism
  • Morpholines / pharmacology
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / enzymology*
  • Neutrophils / cytology*
  • Neutrophils / drug effects
  • Phosphorylation / drug effects
  • Promoter Regions, Genetic / genetics
  • Protein Kinase C / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Pyrazoles / pharmacology
  • Pyrimidines / pharmacology
  • Quinazolines
  • Repressor Proteins / metabolism*
  • Trachea / cytology
  • Trachea / drug effects
  • Trachea / enzymology
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Tyrphostins / pharmacology
  • Vascular Cell Adhesion Molecule-1 / genetics*
  • Vascular Cell Adhesion Molecule-1 / immunology

Substances

  • 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine
  • Antibodies
  • Calmodulin
  • Chromones
  • Isoenzymes
  • Morpholines
  • Pyrazoles
  • Pyrimidines
  • Quinazolines
  • Repressor Proteins
  • Tumor Necrosis Factor-alpha
  • Tyrphostins
  • Vascular Cell Adhesion Molecule-1
  • RTKI cpd
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • E1A-Associated p300 Protein
  • EP300 protein, human
  • Histone Acetyltransferases
  • Proto-Oncogene Proteins c-akt
  • Protein Kinase C
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • HDAC4 protein, human
  • Histone Deacetylases